The FDA announced on 16 January 2013 that it has approved Flublok, the first trivalent influenza vaccine made using an...
The FDA is granting exclusivity to Flublok Influenza vaccine, from Protein Sciences, for a period of 12 years. Flublok is...
Protein Sciences Corporation announced topline data showing that Flublok Quadrivalent � the quadrivalent version of FDA-approved trivalent Flublok influenza vaccine...
The FDA has approved its quadrivalent formulation of Flublok influenza vaccine, from Protein Sciences Corporation. Flublok Quadrivalent protects against 4...
The FDA has approved Flublok vaccine, from Protein Sciences, for Influenza, in all adults aged 18 years and older, granting...
Sanofi announced it will acquire Protein Sciences, a privately held vaccines biotechnology company based in Meriden, Connecticut in the United...
The FDA has approved the 0.5mL dose of its influenza vaccine, Fluzone Quadrivalent, from Sanofi Pasteur, for treating children falling...